Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer.
#WCRD2023 Every 24th of September we celebrate the World Cancer Research Day #WCRD. This year, we have participated in some activities trying to visualize our labor in this topic, sponsored by the Spanish association against cancer (AECC). Check it out some of these activities. https://www.contraelcancer.es/es/eventos/accion-calle-plaza-chamberi-madrid-celebrar-dia-mundial-investigacion-cancer-0 https://www.atresplayer.com/lasexta/programas/que-me-pasa-doctor-lasexta/temporada-1/programa-297-cancer-psoriasis_6508796b7152b0e49dd02eb6/
Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.